Such conclusions were drawn 20 years ago, where a relationship was indicated between the reduced expression of miR-15 and miR-16 in B cells and the increase in the level of Bcl-2 protein together with inhibition of apoptosis of cancer cells in chronic lymphocytic leukemia (CLL) [18]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.